India CL Case Seen Increasing Global Pharma Pressure For IP Protection
This article was originally published in PharmAsia News
Executive Summary
With South Africa's recent expression of interest in following India's lead in enforcing compulsory licensing, Western pharmaceutical companies see a confirmation of their fear the idea will spread throughout emerging markets.